Skip to main content

Information on the use of Mounjaro (Tirzepatide) for weight management

Tirzepatide (Mounjaro™) is a weight loss drug that was approved by the National Institute for Health and Care and Excellence (NICE) in the UK on 23 December 2024.

Please visit www.nhsglos.nhs.uk/your-health-services/healthy-communities/weight-loss-medication/ for more information.

Practice team

Practice management

Val Huxley, Operations Manager

Emma Clement, Finance Manager

For non-medical enquiries, please contact our Operations Manager, Val Huxley.

Clinical administration

Emma Morgan
Emma Coombes
Helen Grover

Reception

Sue Oakes
Sue Llewellyn
Cerys Haikney
Claire Gwynne
Emma Jenkins

Secretaries

Mandy Matthews

Page published: 5 May 2023
Last updated: 5 November 2024